Effect of unfractionated heparin on endothelial glycocalyx in a septic shock model

Acta Anaesthesiologica Scandinavica

Volumn 59, Issue 2, 2015, Pages 160-169

  Yini, S ^a   Heng, Z ^a   Xin, A ^a   Xiaochun, M ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; INTERLEUKIN 6; SODIUM CHLORIDE; SYNDECAN 1; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; FIBRINOLYTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOG; DRUG EFFECT; ENDOTHELIUM; ESCHERICHIA COLI; FEMALE; GLYCOCALYX; HEMODYNAMICS; INFLAMMATION; MALE; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEPTIC SHOCK; THROMBOCYTE COUNT; ANIMAL; BLOOD; DISEASE MODEL; DRUG EFFECTS; STATISTICS AND NUMERICAL DATA; VASCULAR ENDOTHELIUM;

ANIMALS; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; DOGS; ENDOTHELIUM, VASCULAR; FEMALE; FIBRINOLYTIC AGENTS; GLYCOCALYX; HEPARIN; INFLAMMATION; INTERLEUKIN-6; MALE; PARTIAL THROMBOPLASTIN TIME; PLATELET COUNT; SHOCK, SEPTIC; SYNDECAN-1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84921516559     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/aas.12418     Document Type: Article

References (20)

1. Bansch P, Nelson A, Ohlsson T, Bentzer P,. Effect of charge on microvascular permeability in early experimental sepsis in the rat. Microvasc Res 2011; 82: 339-345.
2. Arkill KP, Knupp C, Michel CC, Neal CR, Qvortrup K, Rostgaard J, Squire JM,. Similar endothelial glycocalyx structures in microvessels from a range of mammalian tissues: evidence for a common filtering mechanism? Biophys J 2011; 101: 1046-1056.
3. Nieuwdorp M, Meuwese MC, Vink H, Hoekstra JB, Kastelein JJ, Stroes ES,. The endothelial glycocalyx: a potential barrier between health and vascular disease. Curr Opin Lipidol 2005; 16: 507-511.
4. Johansson PI, Stensballe J, Rasmussen LS, Ostrowski SR,. A high admission syndecan-1 level, a marker of endothelial glycocalyx degradation, is associated with inflammation, protein C depletion, fibrinolysis, and increased mortality in trauma patients. Ann Surg 2011; 254: 194-200.
5. Mulivor AW, Lipowsky HH,. Inflammation- and ischemia-induced shedding of venular glycocalyx. Am J Physiol Heart Circ Physiol 2004; 286: H1672-1680.
6. Schmidt EP, Yang YM, Janssen WJ, Gandjeva A, Perez MJ, Barthel L, Zemans RL, Bowman JC, Koyanagi DE, Yunt ZX, Smith LP, Cheng SS, Overdier KH, Thompson KR, Geraci MW, Douglas IS, Pearse DB, Tuder RM,. The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis. Nat Med 2012; 18: 1217-1223.
7. Zhang XJ, Ma XC,. Clinical research on early therapy of severe infection by low-dose heparin. Chin J Surg 2006; 44: 1209-1211.
8. Zhao C, Ma XC,. Clinical analysis on the effect of low-dose unfractionated heparin on sepsis. Chin J Intern Med 2009; 48: 566-569.
9. Li X, Zheng Z, Li X, Ma XC,. Unfractionated heparin inhibits lipopolysaccharide-induced inflammatory response through blocking p38 MAPK and NF-κB activation on endothelial cell. Cytokine 2012; 60: 114-121.
10. Li X, Li ZL, Zheng Z, Liu YN, Ma XC,. Unfractionated heparin ameliorates lipopolysaccharide-induced lung inflammation by downregulating nuclear factor-κB signaling pathway. Inflammation 2013; 36: 1201-1208.
11. Marechal X, Favory R, Joulin O, Montaigne D, Hassoun S, Decoster B, Zerimech F, Neviere R,. Endothelial glycocalyx damage during endotoxemia coincides with microcirculatory dysfunction and vascular oxidative stress. Shock 2008; 29: 572-576.
12. VanTeeffelen JWGE, Brands J, Jansen C, Spaan JAE, Vink H,. Heparin impairs glycocalyx barrier properties and attenuates shear dependent vasodilation in mice. Hypertension 2007; 50: 261-267.
13. Henrich M, Gruss M, Weigan MA,. Sepsis-induced degradation of endothelial glycocalix. ScientificWorldJournal 2010; 10: 917-923.
14. Constantinescu AA, Vink H, Spaan JAE,. Endothelial cell glycocalyx modulates immobilization of leukocytes at the endothelial surface. Arterioscler Thromb Vasc Biol 2003; 23: 1541-1547.
15. Hayashida K, Chen Y, Bartlett AH, Park PW,. Syndecan-1 is an in vivo suppressor of gram-positive toxic shock. J Biol Chem 2008; 283: 19895-19903.
16. Nelson A, Berkestedt I, Schmidtchen A, Ljunggren L, Bodelsson M,. Increased levels of glycosaminoglycans during septic shock: relation to mortality and the antibacterial actions of plasma. Shock 2008; 30: 623-627.
17. Lipowsky HH,. The endothelial glycocalyx as a barrier to leukocyte adhesion and its mediation by extracellular proteases. Ann Biomed Eng 2012; 40: 840-848.
18. Lipowsky HH, Gao LJ, Lescanic A,. Shedding of the endothelial glycocalyx in arterioles, capillaries, and venules and its effect on capillary hemodynamics during inflammation. Am J Physiol Heart Circ Physiol 2011; 301: 2235-2245.
19. Chappell D, Hofmann-Kiefer K, Jacob M, Rehm M, Briegel J, Welsch U, Conzen P, Becker BF,. TNF-α induced shedding of the endothelial glycocalyx is prevented by hydrocortisone and antithrombin. Basic Res Cardiol 2009; 104: 78-89.
20. Rubio-Gayosso I, Platts SH, Duling BR,. Reactive oxygen species mediate modification of glycocalyx during ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 2006; 290: H2247-2256.